SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-118132
Filing Date
2021-09-22
Accepted
2021-09-22 08:35:44
Documents
16
Period of Report
2021-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2127566d3_8k.htm   iXBRL 8-K 37506
2 EXHIBIT 1.1 tm2127566d3_ex1-1.htm EX-1.1 345787
3 EXHIBIT 4.1 tm2127566d3_ex4-1.htm EX-4.1 90312
4 EXHIBIT 5.1 tm2127566d3_ex5-1.htm EX-5.1 11761
5 EXHIBIT 99.1 tm2127566d3_ex99-1.htm EX-99.1 11891
  Complete submission text file 0001104659-21-118132.txt   792500

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lptx-20210922.xsd EX-101.SCH 3182
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20210922_lab.xml EX-101.LAB 34593
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20210922_pre.xml EX-101.PRE 22708
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2127566d3_8k_htm.xml XML 3716
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 211268230
SIC: 2834 Pharmaceutical Preparations